Mari Thomas

2.3k total citations
43 papers, 1.1k citations indexed

About

Mari Thomas is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Mari Thomas has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 19 papers in Hematology and 13 papers in Genetics. Recurrent topics in Mari Thomas's work include Complement system in diseases (25 papers), Platelet Disorders and Treatments (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). Mari Thomas is often cited by papers focused on Complement system in diseases (25 papers), Platelet Disorders and Treatments (13 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (10 papers). Mari Thomas collaborates with scholars based in United Kingdom, United States and Canada. Mari Thomas's co-authors include Marie Scully, James T. B. Crawley, Matthew Stubbs, Rens de Groot, Beverley J. Hunt, Catherine Nelson‐Piercy, Munther A. Khamashta, Kate Bramham, Maria Mouyis and John‐Paul Westwood and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mari Thomas

41 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mari Thomas United Kingdom 15 687 494 366 348 132 43 1.1k
V. Aumann Germany 9 1.3k 1.9× 902 1.8× 713 1.9× 400 1.1× 24 0.2× 30 1.7k
John‐Paul Westwood United Kingdom 13 995 1.4× 580 1.2× 536 1.5× 380 1.1× 27 0.2× 23 1.2k
Betty Cheung United Kingdom 4 470 0.7× 483 1.0× 286 0.8× 383 1.1× 89 0.7× 8 868
Pascale Poullin France 14 514 0.7× 388 0.8× 285 0.8× 219 0.6× 37 0.3× 49 822
L Gugliotta Italy 21 363 0.5× 957 1.9× 137 0.4× 622 1.8× 179 1.4× 66 1.4k
Peter Hewins United Kingdom 17 369 0.5× 55 0.1× 252 0.7× 231 0.7× 267 2.0× 37 1.1k
Ayad Hamdan United States 11 401 0.6× 233 0.5× 212 0.6× 119 0.3× 70 0.5× 28 704
Christian Rose France 13 369 0.5× 516 1.0× 212 0.6× 303 0.9× 62 0.5× 19 879
HM Tsai United States 8 797 1.2× 799 1.6× 295 0.8× 316 0.9× 15 0.1× 11 1.2k
Denis F. Noubouossie United States 15 339 0.5× 404 0.8× 11 0.0× 289 0.8× 62 0.5× 37 1.0k

Countries citing papers authored by Mari Thomas

Since Specialization
Citations

This map shows the geographic impact of Mari Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Thomas more than expected).

Fields of papers citing papers by Mari Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Thomas. The network helps show where Mari Thomas may publish in the future.

Co-authorship network of co-authors of Mari Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Thomas. A scholar is included among the top collaborators of Mari Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Thomas. Mari Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Arulkumaran, Nishkantha, Mari Thomas, Matthew C. Stubbs, et al.. (2024). A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX). Scientific Reports. 14(1). 16876–16876. 1 indexed citations
4.
Alikhan, Raza, Keith Gomez, Anthony Maraveyas, et al.. (2024). Cancer‐associated venous thrombosis in adults (second edition): A British Society for Haematology Guideline. British Journal of Haematology. 205(1). 71–87. 10 indexed citations
5.
6.
Thomas, Mari, Rens de Groot, Andrew J. Doyle, et al.. (2023). Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsia. Journal of Thrombosis and Haemostasis. 22(2). 455–465. 2 indexed citations
7.
Underwood, Mary, Mari Thomas, Marie Scully, & James T. B. Crawley. (2023). ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 22(4). 1069–1079. 3 indexed citations
8.
Underwood, Mary, Ferras Alwan, Mari Thomas, Marie Scully, & James T. B. Crawley. (2023). Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 21(6). 1544–1552. 9 indexed citations
9.
Doyle, Andrew J., Matthew Stubbs, Tina Dutt, et al.. (2022). Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy. Blood. 141(3). 285–294. 10 indexed citations
10.
Patel, Aisha, et al.. (2022). Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study. Thrombosis Research. 213. 27–29. 10 indexed citations
11.
Thomas, Mari, et al.. (2021). Comparing pregnancy outcomes in patients with criteria and non-criteria autoimmune disease: A systematic review. Lupus. 31(1). 5–18. 5 indexed citations
12.
Hughes, D.J., et al.. (2021). Venous thromboembolism in women with ovarian cancer undergoing neoadjuvant chemotherapy prior to cytoreductive surgery: A retrospective study. Acta Obstetricia Et Gynecologica Scandinavica. 100(11). 2091–2096. 12 indexed citations
13.
Stubbs, Matthew, Paul Coppo, Chris Cheshire, et al.. (2021). Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura. Haematologica. 107(3). 574–582. 2 indexed citations
14.
Thomas, Mari, et al.. (2021). Use of anti-factor Xa levels in cancer patients taking direct oral anticoagulants. Thrombosis Research. 200. 81–82. 1 indexed citations
15.
16.
Stubbs, Matthew, Maria Mouyis, & Mari Thomas. (2018). Deep vein thrombosis. BMJ. 360. k351–k351. 71 indexed citations
17.
Patriquin, Christopher J., Mari Thomas, Tina Dutt, et al.. (2016). Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura. British Journal of Haematology. 173(5). 779–785. 60 indexed citations
18.
Thomas, Mari, Rens de Groot, Marie Scully, & James T. B. Crawley. (2015). Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. EBioMedicine. 2(8). 942–952. 91 indexed citations
19.
Camilleri, Raymond, Marie Scully, Mari Thomas, et al.. (2012). A phenotype–genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom. Journal of Thrombosis and Haemostasis. 10(9). 1792–1801. 52 indexed citations
20.
Chan, Ka Lok, et al.. (2000). Measurements of the dielectric properties of peripheral blood mononuclear cells and trophoblast cells using AC electrokinetic techniques. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1500(3). 313–322. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Aumann Breakdown of academic impact, for papers by John‐Paul Westwood Breakdown of academic impact, for papers by Betty Cheung Breakdown of academic impact, for papers by Pascale Poullin Breakdown of academic impact, for papers by L Gugliotta Breakdown of academic impact, for papers by Peter Hewins Breakdown of academic impact, for papers by Ayad Hamdan Breakdown of academic impact, for papers by Christian Rose Breakdown of academic impact, for papers by HM Tsai Breakdown of academic impact, for papers by Denis F. Noubouossie
Rankless by CCL
2026